Additional Information


Content

Anadin and Advil maker narrows media review

LONDON - Wyeth, the pharmaceutical company behind painkiller Anadin, has cut the shortlist on its £5m media review to two, dropping incumbent Mediaedge:cia.

Share this article

Wyeth has shortlisted BBJ and Optimedia, which was also an incumbent handling the Centrum vitamin supplement. A decision is expected next week.

The review will see Wyeth centralise its media planning and buying business, which was previously split between Optimedia and Mediaedge:cia.

Mediaedge:cia had handled the bulk of the account including Anadin, Advil, Robitussin cough remedy and Preparation H.

Wyeth's advertising account is held by Publicis, although there has been little activity since last year when it launched a £2.5m Christmas TV campaign that ran throughout the party season followed by a campaign for Centrum. A campaign for Anadin Ultra ran in the Autumn, which with the Anadin work from last year is set to run again this Christmas.

Wyeth, which was previously known as Whitehall Laboratories, specialises in the manufacture of analgesics, multivitamins and antacids.

If you have an opinion on this or any other issue raised on Brand Republic, join the debate in the Forum here.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Additional Information

Latest jobs Jobs web feed

FROM THE BLOGS

The Wall blogs

Back to top ^